NA
PHAR

NewEdge Advisors’s Pharming Group PHAR Stock Holding History

NewEdge Advisors’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.8K Sell
2,150
-26,718
-93% -$453K ﹤0.01% 3031
2025
Q4 		$510K Buy
28,868
+28,615
+11,310% +$450K ﹤0.01% 1949
2025
Q3 		$3.67K Buy
+253
New +$3.15K ﹤0.01% 3621

Other funds holding PHAR

SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SHIM
Stone House Investment Management Tunkhannock, Pennsylvania $558M AUM 14.72% 1-Year Est. Return

NewEdge Advisors's PHAR Position: Q1 2026 in Review

NewEdge Advisors reduced its Pharming Group (PHAR) stake by 93% in Q1 2026, selling an estimated $453K and leaving 2,150 shares worth $35.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3031.

NewEdge Advisors first reported a position in PHAR in Q3 2025 and has held it in 3 quarters since. The position peaked at $510K in Q4 2025. 12 funds tracked by Wall St. Rank hold PHAR as of Q1 2026.

  • NewEdge Advisors held 2,150 shares of Pharming Group worth $35.8K as of Q1 2026.
  • NewEdge Advisors sold 26,718 Pharming Group shares in Q1 2026, an estimated $453K.
  • Pharming Group made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #3031 holding.
  • NewEdge Advisors first reported a position in Pharming Group in Q3 2025 and has held it in 3 quarters since.
  • NewEdge Advisors's Pharming Group position peaked at $510K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held Pharming Group as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.